Parametric Portfolio Owns J&J, Pfizer and Merck Shares the Most in Q3

Wall St. Watchdog reveals information regarding Parametric Portfolio Associates’ top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 269 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $2.155 billion.

  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Parametric Portfolio Associates reported holding 3,366,303 shares with a market value of $223,926,464. This comprised 0.99% of the total portfolio. On 09/30/2011, Parametric Portfolio Associates reported holding 3,670,971 shares with a market value of $233,804,138. This comprised 1.12% of the total portfolio. The net change in shares for this position over the two quarters is 304,668. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Parametric Portfolio Associates reported holding 9,972,578 shares with a market value of $205,435,111. This comprised 0.91% of the total portfolio. On 09/30/2011, Parametric Portfolio Associates reported holding 10,671,935 shares with a market value of $188,679,814. This comprised 0.91% of the total portfolio. The net change in shares for this position over the two quarters is 699,357. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Parametric Portfolio Associates reported holding 3,919,679 shares with a market value of $138,325,475. This comprised 0.61% of the total portfolio. On 09/30/2011, Parametric Portfolio Associates reported holding 4,314,031 shares with a market value of $141,068,817. This comprised 0.68% of the total portfolio. The net change in shares for this position over the two quarters is 394,352. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Parametric Portfolio Associates reported holding 1,886,289 shares with a market value of $99,256,525. This comprised 0.44% of the total portfolio. On 09/30/2011, Parametric Portfolio Associates reported holding 2,139,003 shares with a market value of $109,388,612. This comprised 0.53% of the total portfolio. The net change in shares for this position over the two quarters is 252,714. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Parametric Portfolio Associates reported holding 2,045,574 shares with a market value of $105,510,711. This comprised 0.47% of the total portfolio. On 09/30/2011, Parametric Portfolio Associates reported holding 2,274,287 shares with a market value of $104,890,114. This comprised 0.5% of the total portfolio. The net change in shares for this position over the two quarters is 228,713. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, Parametric Portfolio Associates reported holding 1,351,432 shares with a market value of $78,856,055. This comprised 0.35% of the total portfolio. On 09/30/2011, Parametric Portfolio Associates reported holding 1,633,540 shares with a market value of $89,779,357. This comprised 0.43% of the total portfolio. The net change in shares for this position over the two quarters is 282,108. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, Parametric Portfolio Associates reported holding 2,419,247 shares with a market value of $70,061,391. This comprised 0.31% of the total portfolio. On 09/30/2011, Parametric Portfolio Associates reported holding 2,498,485 shares with a market value of $78,402,457. This comprised 0.38% of the total portfolio. The net change in shares for this position over the two quarters is 79,238. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, Parametric Portfolio Associates reported holding 1,540,893 shares with a market value of $57,829,712. This comprised 0.26% of the total portfolio. On 09/30/2011, Parametric Portfolio Associates reported holding 1,719,974 shares with a market value of $63,587,441. This comprised 0.31% of the total portfolio. The net change in shares for this position over the two quarters is 179,081. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Allergan Inc. (NYSE:AGN): On 06/30/2011, Parametric Portfolio Associates reported holding 557,927 shares with a market value of $46,447,423. This comprised 0.21% of the total portfolio. On 09/30/2011, Parametric Portfolio Associates reported holding 705,813 shares with a market value of $58,144,873. This comprised 0.28% of the total portfolio. The net change in shares for this position over the two quarters is 147,886. About Company: Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
  • Celgene Corporation (NASDAQ:CELG): On 06/30/2011, Parametric Portfolio Associates reported holding 709,540 shares with a market value of $42,799,453. This comprised 0.19% of the total portfolio. On 09/30/2011, Parametric Portfolio Associates reported holding 882,433 shares with a market value of $54,631,427. This comprised 0.26% of the total portfolio. The net change in shares for this position over the two quarters is 172,893. About Company: Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

(Note: Data regarding Parametric Portfolio Associates’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet